If your antidepressant is not working the way you hoped, you may be asking what comes next. Roughly half of people with depression do not fully respond to the first antidepressant they try. For many, that leads to a familiar cycle of switching medications, adjusting doses, and waiting weeks to
“They’re going to figure out I don’t really belong here.” For many high-achievers, that thought is a familiar one. Imposter syndrome is the persistent sense that your accomplishments are a fluke and that exposure is just one mistake away. For many people, imposter syndrome shows up as a passing thought.
Mental health awareness in 2026 looks different in Southern California than it did even a few years ago. Conversations that once felt taboo now happen in workplaces, schools, and family group chats. But awareness alone isn’t the goal anymore. Now the real challenge is closing the gap between the people
If you’ve spent your life feeling like you’re constantly drifting, missing details, or struggling to follow through on tasks others seem to handle easily, there’s a name for what you may be experiencing. Inattentive ADHD is a real, recognized form of attention-deficit/hyperactivity disorder, but it often looks very different from
There’s nothing worse than struggling night after night to fall asleep, stay asleep, or feel rested in the morning. Sleep disorders and insomnia affect a huge portion of the population. The data paints an exhausting picture: 10-15% of people in the US experience chronic insomnia Women are 40% more likely
The Trump Administration in April 2026 announced a federal order directing agencies to speed up research and regulatory review of several psychedelic compounds, including ibogaine, a substance showing early promise in treating addiction, PTSD, and treatment-resistant depression. The move is part of a broader shift in how the health agencies
